Literature DB >> 12023989

Genotype-phenotype correlation in inherited severe insulin resistance.

Nicola Longo1, Yuhuan Wang, Shelley A Smith, Sharon D Langley, Linda A DiMeglio, Daniel Giannella-Neto.   

Abstract

The insulin receptor is a ligand-activated tyrosine kinase. Mutations in the corresponding gene cause the rare inherited insulin-resistant disorders leprechaunism and Rabson-Mendenhall syndrome. Patients with the most severe syndrome, leprechaunism, have growth restriction, altered glucose homeostasis and early death (usually before 1 year of age). Rabson-Mendenhall syndrome is less severe, with survival up to 5-15 years of age. These disorders are transmitted as autosomal recessive traits. Here we report six new patients and correlate mutations in the insulin receptor gene with survival. Patients with leprechaunism were homozygous or compound heterozygous for mutations in the extracellular domain of the insulin receptor and their cells had markedly impaired insulin binding (<10% of controls). Mutations in their insulin receptor gene inserted premature stop codons (E124X, R372X, G650X, E665X and C682X), resulting in decreased levels of mature mRNA, or affected the extracellular domain of the receptor (R86P, A92V, DeltaN281, I898T and R899W). Three patients with Rabson-Mendenhall syndrome had at least one missense mutation in the intracellular domain of the insulin receptor (P970T, I1116T, R1131W and R1174W). Expression studies in CHO cells indicated that the R86P, A92V, DeltaN281, I898T, R899W and R1131W mutations markedly impaired insulin binding (<5% of control), while the P970T, I1116T and R1174W mutant receptors retained significant insulin-binding activity. These results indicate that mutations in the insulin receptor retaining residual insulin-binding correlate with prolonged survival in our series of patients with extreme insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023989     DOI: 10.1093/hmg/11.12.1465

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  34 in total

1.  Congenital disease SNPs target lineage specific structural elements in protein kinases.

Authors:  Ali Torkamani; Natarajan Kannan; Susan S Taylor; Nicholas J Schork
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

Review 2.  Rabson-Mendenhall syndrome: two case reports and a brief review of the literature.

Authors:  Renuka J Bathi; Sameena Parveen; Sunil Mutalik; Reema Rao
Journal:  Odontology       Date:  2010-02-16       Impact factor: 2.634

3.  Severe insulin resistance alters metabolism in mesenchymal progenitor cells.

Authors:  Bharti Balhara; Alison Burkart; Vehap Topcu; Youn-Kyoung Lee; Chad Cowan; C Ronald Kahn; Mary-Elizabeth Patti
Journal:  Endocrinology       Date:  2015-03-26       Impact factor: 4.736

4.  Hypoglycaemia revealing heterozygous insulin receptor mutations.

Authors:  V Preumont; C Feincoeur; O Lascols; C Courtillot; P Touraine; D Maiter; C Vigouroux
Journal:  Diabetes Metab       Date:  2016-07-26       Impact factor: 6.041

Review 5.  Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.

Authors:  Latha Ramalingam; Eunjin Oh; Debbie C Thurmond
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

Review 6.  Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure.

Authors:  J R Porter; T G Barrett
Journal:  J Med Genet       Date:  2005-03-16       Impact factor: 6.318

7.  Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.

Authors:  Haruka Okamoto; Katie Cavino; Erqian Na; Elizabeth Krumm; Sun Y Kim; Xiping Cheng; Andrew J Murphy; George D Yancopoulos; Jesper Gromada
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

8.  Metreleptin improves blood glucose in patients with insulin receptor mutations.

Authors:  Rebecca J Brown; Elaine Cochran; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2013-08-22       Impact factor: 5.958

9.  PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.

Authors:  Christel Thauvin-Robinet; Martine Auclair; Laurence Duplomb; Martine Caron-Debarle; Magali Avila; Judith St-Onge; Martine Le Merrer; Bernard Le Luyer; Delphine Héron; Michèle Mathieu-Dramard; Pierre Bitoun; Jean-Michel Petit; Sylvie Odent; Jeanne Amiel; Damien Picot; Virginie Carmignac; Julien Thevenon; Patrick Callier; Martine Laville; Yves Reznik; Cédric Fagour; Marie-Laure Nunes; Jacqueline Capeau; Olivier Lascols; Frédéric Huet; Laurence Faivre; Corinne Vigouroux; Jean-Baptiste Rivière
Journal:  Am J Hum Genet       Date:  2013-06-27       Impact factor: 11.025

10.  Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism.

Authors:  Sara G I Suliman; Juraj Stanik; Laura J McCulloch; Natalie Wilson; Emma L Edghill; Nadezda Misovicova; Daniela Gasperikova; Vilja Sandrikova; Katherine S Elliott; Lubomir Barak; Sian Ellard; Emanuela V Volpi; Iwar Klimes; Anna L Gloyn
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.